Patents by Inventor Phillip Gregory Mattingly

Phillip Gregory Mattingly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ISOLATED HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES AND METHODS AND KITS FOR DETECTING HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES
    Publication number: 20090286329
    Abstract: The present disclosure relates to isolated human autoantibodies and assays and kits for detecting human autoantibodies reactive with at least one natriuretic peptide or natriuretic peptide fragment in a test sample.
    Type: Application
    Filed: May 19, 2009
    Publication date: November 19, 2009
    Applicant: ABBOTT LABORATOIRES
    Inventors: Maciej Adamczyk, Roy Jeffrey Brashear, Phillip Gregory Mattingly
  • Chemiluminescent acridinium salts
    Patent number: 5783699
    Abstract: Acridinium sulfonylamides and isomers, such as phenanthridinium sulfonylamides, may be employed in applications including chemiluminmescent immunoassays. Methods for synthesis of these compounds include contacting an amine with a sulfonylhalide to form a sulfonamide and acylating with an activated carboxylic acid of an acridine or isomer thereof. The N-sulfonyl-9-acridinium carboxamide and isomers may be conjugated to antigens, haptens, antibodies, and nucleic acids for use in chemiluminescent assays.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: July 21, 1998
    Assignee: Abbott Laboratories
    Inventors: Phillip Gregory Mattingly, Larry Gene Bennett
  • Chemiluminescent phenanthridinium
    Patent number: 5669819
    Abstract: Acridinium sulfonylamides and isomers, such as phenanthridinium sulfonylamides, may be employed in applications including chemiluminmescent immunoassays. Methods for synthesis of these compounds include contacting an amine with a sulfonylhalide to form a sulfonamide and acylating with an activated carboxylic acid of an acridine or isomer thereof. The N-sulfonyl-9-acridinium carboxamide and isomers may be conjugated to antigens, haptens, antibodies, and nucleic acids for use in chemiluminescent assays.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: September 23, 1997
    Assignee: Abbott Laboratories
    Inventors: Phillip Gregory Mattingly, Larry Gene Bennett